At the time of writing, Tonix Pharmaceuticals Holding Corp [TNXP] stock is trading at $35.54, up 4.56%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The TNXP shares have gain 3.55% over the last week, with a monthly amount drifted -3.92%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Previously, ROTH Capital upgraded its rating to Buy on April 18, 2019, and kept the price target unchanged to $4. On August 18, 2017, upgrade upgraded it’s rating to Buy but maintained its price target of $6 on the stock. ROTH Capital downgraded its rating to a Neutral. Oppenheimer reiterated its recommendation of a Outperform and reduced its price target to $10 on February 17, 2016. In a note dated June 12, 2015, Oppenheimer initiated an Outperform rating and provided a target price of $18 on this stock.
For the past year, the stock price of Tonix Pharmaceuticals Holding Corp fluctuated between $6.76 and $130.00. Tonix Pharmaceuticals Holding Corp [NASDAQ: TNXP] shares were valued at $35.54 at the most recent close of the market.
Analyzing the TNXP fundamentals
According to Tonix Pharmaceuticals Holding Corp [NASDAQ:TNXP], the company’s sales were 10.04M for trailing twelve months, which represents an -2.14% plunge. Gross Profit Margin for this corporation currently stands at 0.3% with Operating Profit Margin at -7.22%, Pretax Profit Margin comes in at -11.46%, and Net Profit Margin reading is -11.46%. To continue investigating profitability, this company’s Return on Assets is posted at -0.6, Equity is -1.06 and Total Capital is -0.4. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.0.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 34.06 points at the first support level, and at 32.57 for the second support level. However, for the 1st resistance point, the stock is sitting at 36.56, and for the 2nd resistance point, it is at 37.57.
Ratios To Look Out For
It is important to note that Tonix Pharmaceuticals Holding Corp [NASDAQ:TNXP] has a current ratio of 12.31. As well, the Quick Ratio is 11.64, while the Cash Ratio is 10.84. Considering the valuation of this stock, the price to sales ratio is 26.04, the price to book ratio is 1.36.
Transactions by insiders
Recent insider trading involved LEDERMAN SETH, Chief Executive Officer, that happened on May 15 ’25 when 4000.0 shares were purchased.
